anti-BMP therapeutic (Mapi Pharma)

N/A

Report date: 2025/03/14 16:21:29
NME

Base Information

Drug Nameanti-BMP therapeutic (Mapi Pharma)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTel-Aviv Sourasky Medical Center
China Registration ClassN/A

Develop Information

Active CompaniesMapi Pharma Ltd
Inactive CompaniesN/A
Active IndicationsMultiple Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A